I-21 Leonid Gibiansky
vc-MMAE antibody-drug conjugates: a unified model describes pharmacokinetics of eight different compounds
Wednesday 10:20-11:40 |
I-23 Britta Goebel
Modeling & Simulation of Long-Term Body Weight Loss during Obesity Pharmacotherapy
Wednesday 10:20-11:40 |
I-27 Gopichand Gottipati
Item Response Modeling to Leverage Data from Historical Parkinson’s Disease Trials while Integrating Data from a Newer Version of the Clinical Endpoint
Wednesday 10:20-11:40 |
I-29 Sylvain Goutelle
A nonparametric, multiple-model approach to optimize initial dosing and attainment of a target exposure interval: application to busulfan in pediatrics
Wednesday 10:20-11:40 |
I-51 Itziar Irurzun-Arana
Attractor analysis of Boolean models for Systems Pharmacology Networks
Wednesday 10:20-11:40 |
I-64 Katrine Knøsgaard
A model-based approach for joint analysis of pain intensity and opioid consumption in postoperative pain
Wednesday 10:20-11:40 |
I-68 Manish Kumar
Elucidating metabolic variations in gut microbiota during health and malnutrition based on genome scale metabolic modeling approach
Wednesday 10:20-11:40 |
II-10 Yasunori Aoki
Model Averaging and Selection methods for model structure and parameter uncertainty quantification
Wednesday 15:10-16:30 |
II-19 Levy Batista
Mixed-effects ARX model identification of dynamical systems
Wednesday 15:10-16:30 |
II-22 Roberto Bizzotto
Mixed-effect deconvolution: a new method applied to oral paracetamol absorption
Wednesday 15:10-16:30 |
II-38 Letizia Carrara
Methods and tools for multiscale modelling in Systems Pharmacology: a review
Wednesday 15:10-16:30 |
III-06 Kurt Long
Identification of causal pathways determining the relationship between pathogen-specific infection and impaired growth among children < 59 months in Mirzapur, Bangladesh
Thursday 10:05-11:30 |
III-13 Victor Mangas-Sanjuan
Exploring Inter-study variability in the context of modeling unperturbed xenograft data
Thursday 10:05-11:30 |
III-18 Emma Martin
Modelling based methods to account for dropout in xenograft experiments
Thursday 10:05-11:30 |
III-41 Stine Timmermann Ottesen
Analysing the contribution to receptor occupancy from active metabolites
Thursday 10:05-11:30 |
III-53 Thomas Peyret
A mechanistic maternal-fetal growth energy budget model
Thursday 10:05-11:30 |
III-58 Manuel Prado-Velasco
Bridging the gap between open and specialized modelling tools in PBPK/PK/PD with PhysPK/EcosimPro modelling system: PBPK model of methotrexate and 6-mercaptopurine in humans with focus in reusability and multilevel modelling features
Thursday 10:05-11:30 |
III-74 Yue Ruan
Bayesian hierarchical model of glucose-insulin regulation over 12-week home use of closed-loop insulin delivery
Thursday 10:05-11:30 |
IV-06 Johannes Schropp
Development and implementation of drug-drug interaction mechanisms with target-mediated drug disposition
Thursday 14:40-16:00 |
IV-07 Partho Sen
Identification of foods with optimal nutritional value through data mining.
Thursday 14:40-16:00 |
IV-15 Spyros Stamatelos
High-Resolution Image-based Computational Modeling of Breast Tumor Microvasculature
Thursday 14:40-16:00 |
IV-31 Michel Tod
Comparison of the mechanistic static in vivo approach to a PBPK approach for prediction of metabolic drug-drug interactions.
Thursday 14:40-16:00 |
IV-41 Vladimir Vainstein
Dose translation of a hematopoietic acute radiation syndrome protection agent (recombinant human Interleukin-12) to humans.
Thursday 14:40-16:00 |
IV-42 Pyry Välitalo
A mathematical method assessing the informativeness of total test score on the basis of an item response theory model: A case study on pain in children
Thursday 14:40-16:00 |
IV-43 Willem van den Brink
Finding underlying longitudinal patterns in pharmaco-metabolomics data
Thursday 14:40-16:00 |
IV-46 Michiel Van Esdonk
Development of a semi-population deconvolution method for the analysis of growth hormone profiles
Thursday 14:40-16:00 |
